Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 1
2008 2
2009 2
2010 2
2011 8
2012 6
2013 4
2014 5
2015 2
2016 2
2017 6
2018 3
2019 2
2020 3
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann P, Goergen H, Kobe C, Lohri A, Greil R, Eichenauer DA, Zijlstra JM, Markova J, Meissner J, Feuring-Buske M, Hüttmann A, Dierlamm J, Soekler M, Beck HJ, Willenbacher W, Ludwig WD, Pabst T, Topp MS, Hitz F, Bentz M, Keller UB, Kühnhardt D, Ostermann H, Schmitz N, Hertenstein B, Aulitzky W, Maschmeyer G, Vieler T, Eich H, Baues C, Stein H, Fuchs M, Kuhnert G, Diehl V, Dietlein M, Engert A. Borchmann P, et al. Among authors: markova j. Lancet. 2017 Dec 23;390(10114):2790-2802. doi: 10.1016/S0140-6736(17)32134-7. Epub 2017 Oct 20. Lancet. 2017. PMID: 29061295 Clinical Trial.
A novel germline hyperactivating JAK2 mutation L604F.
Dvořáček L, Marková J, Holoubek A, Grebeňová D, Kundrát D, Kuželová K, Schwarz J. Dvořáček L, et al. Among authors: markova j. Ann Hematol. 2023 Oct;102(10):2725-2734. doi: 10.1007/s00277-023-05423-y. Epub 2023 Aug 28. Ann Hematol. 2023. PMID: 37639050 Free PMC article.
DNMT3A mutations in AML: a new prognostic factor?
Schwarz J, Marková J. Schwarz J, et al. Among authors: markova j. Leuk Res. 2013 Nov;37(11):1432-3. doi: 10.1016/j.leukres.2013.08.012. Epub 2013 Sep 6. Leuk Res. 2013. PMID: 24045027 No abstract available.
Nature of frequent deletions in CEBPA.
Fuchs O, Kostecka A, Provaznikova D, Krasna B, Brezinova J, Filkukova J, Kotlin R, Kouba M, Kobylka P, Neuwirtova R, Jonasova A, Caniga M, Schwarz J, Markova J, Maaloufova J, Sponerova D, Novakova L, Cermak J. Fuchs O, et al. Among authors: markova j. Blood Cells Mol Dis. 2009 Nov-Dec;43(3):260-3. doi: 10.1016/j.bcmd.2009.07.001. Epub 2009 Aug 3. Blood Cells Mol Dis. 2009. PMID: 19651529
Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.
Hudecova S, Markova J, Simko V, Csaderova L, Stracina T, Sirova M, Fojtu M, Svastova E, Gronesova P, Pastorek M, Novakova M, Cholujova D, Kopacek J, Pastorekova S, Sedlak J, Krizanova O. Hudecova S, et al. Among authors: markova j. Oncotarget. 2016 Sep 20;7(38):61403-61418. doi: 10.18632/oncotarget.8968. Oncotarget. 2016. PMID: 27528021 Free PMC article.
45 results